Related Experiment Videos
Consensus panel on cervical cancer highlights the HPV connection
Journal of the National Cancer Institute
|May 1, 1996
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Pembrolizumab versus ipilimumab for advanced melanoma: 10-year follow-up of the phase III KEYNOTE-006 study.
Annals of oncology : official journal of the European Society for Medical Oncology·2024
Outcomes of patients with non-melanoma solid tumours receiving self-funded pembrolizumab at Chris O'Brien Lifehouse.
Internal medicine journal·2016
Progression of KRAS mutant pancreatic adenocarcinoma during vemurafenib treatment in a patient with metastatic melanoma.
Internal medicine journal·2014
Plasma insulin-like growth Factor-Binding protein 7 predicts 20-Year Cancer-Specific and overall survival in ARIC.
Journal of the National Cancer Institute·2026
A taxonomy of work-related outcomes in cancer survivors to advance systematic assessments in research and practice.
Journal of the National Cancer Institute·2026
Recent trends in Early-Onset cancer incidence rates.
Journal of the National Cancer Institute·2026
Recurrence Score® gene group components and outcomes in the RxPONDER trial (SWOG S1007).
Journal of the National Cancer Institute·2026
Prevalence of industry ties in the US cancer ecosystem: a systematic review and meta-analysis.
Journal of the National Cancer Institute·2026
Mortality after emergency presentation: evidence from a cohort of 929 378 Medicare beneficiaries with common cancers diagnosed 2008-2017.
Journal of the National Cancer Institute·2026
US real-world biomarker testing differences and treatment choice in advanced ovarian cancer: results of a retrospective study.
Future oncology (London, England)·2026
Epitranscriptomic control of epithelial-mesenchymal transition in cancer: mechanisms, plasticity, and therapeutic opportunities.
Frontiers in cell and developmental biology·2026
A cross-validated deep learning framework for automated detection of DMBA-induced ovarian cancer from histopathological images with CA-125 biomarker support.
Frontiers in artificial intelligence·2026